| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,218 |
16,000 |
$2.76M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,015 |
11,875 |
$2.59M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,201 |
9,184 |
$2.59M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,396 |
3,105 |
$312K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,813 |
664 |
$231K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,300 |
2,068 |
$156K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,233 |
1,205 |
$151K |
| 80053 |
Comprehensive metabolic panel |
7,635 |
7,033 |
$136K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,635 |
1,479 |
$84K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
510 |
494 |
$63K |
| 36415 |
Collection of venous blood by venipuncture |
8,940 |
8,251 |
$51K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
518 |
500 |
$37K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,914 |
1,849 |
$31K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,366 |
14,867 |
$29K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,032 |
933 |
$18K |
| 71045 |
Radiologic examination, chest; single view |
349 |
332 |
$18K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
257 |
253 |
$18K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
24 |
24 |
$16K |
| J7050 |
Infusion, normal saline solution, 250 cc |
111 |
91 |
$13K |
| 71046 |
Radiologic examination, chest; 2 views |
461 |
422 |
$9K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
383 |
249 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
221 |
195 |
$6K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
208 |
205 |
$5K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
40 |
13 |
$5K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
90 |
39 |
$4K |
| 87081 |
|
289 |
276 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12 |
12 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,841 |
2,520 |
$3K |
| 81001 |
|
3,086 |
2,854 |
$2K |
| 86140 |
|
752 |
699 |
$2K |
| 83690 |
|
534 |
487 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12 |
12 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
105 |
101 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,582 |
1,139 |
$1K |
| 84484 |
|
137 |
103 |
$820.34 |
| J2704 |
Injection, propofol, 10 mg |
891 |
577 |
$790.43 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
27 |
26 |
$778.80 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
543 |
459 |
$545.51 |
| 83605 |
|
51 |
49 |
$461.77 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
87 |
79 |
$456.25 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
94 |
82 |
$367.34 |
| 85610 |
|
89 |
81 |
$341.28 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
840 |
770 |
$315.56 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
504 |
433 |
$256.71 |
| 83880 |
|
16 |
12 |
$242.73 |
| 96376 |
|
13 |
12 |
$233.51 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
229 |
162 |
$215.20 |
| 84443 |
Thyroid stimulating hormone (TSH) |
12 |
12 |
$189.61 |
| 83735 |
|
43 |
40 |
$171.50 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
315 |
274 |
$95.60 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
110 |
77 |
$33.31 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
12 |
12 |
$15.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$2.85 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
716 |
336 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
116 |
104 |
$0.00 |
| 81025 |
|
13 |
13 |
$0.00 |